Outcomes and Multidisciplinary Treatment of Insomnia. David N. Neubauer, M.D. Johns Hopkins University School of Medicine
|
|
- Whitney Benson
- 6 years ago
- Views:
Transcription
1 Outcomes and Multidisciplinary Treatment of Insomnia David N. Neubauer, M.D. Johns Hopkins University School of Medicine
2 Insomnia as a Disorder INSOMNIA More than 1 type of disturbance may be present Symptoms may vary over time Difficulty Falling Asleep Difficulty Staying Asleep (eg, inability to return to sleep after awakening) Waking Too Early Poor Quality of Sleep Next-Day Consequences Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association Press; 1994.
3 Insomnia Epidemiology Prevalence approximately 30% of general population 10% of population has associated symptoms of daytime functional impairment up to 50% prevalence in clinical practices NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. (June 15, 2005)
4 Insomnia Consequences Nighttime experience Daytime complaints Quality of life Absenteeism and decreased productivity Increased healthcare costs Societal burden Future health risks Increased fall risk
5 Insomnia Daytime Complaints Fatigue, exhaustion, tiredness Poor concentration and memory Irritability, moodiness Relationship problems Decreased enjoyment
6 Insomnia and Quality of Life Physical Functioning 100 Mental Health Physical Role Emotional Role Bodily Pain Social Functioning 100 Vitality General Health Good Sleepers (n=391) Mild Insomnia (n=422) Severe Insomnia (n=240) Axes represent subscales of the SF-36. All P values <.05 (range ). SF-36: Short Form Health Survey of the Medical Outcomes Study (36 item). Léger D, et al. Psychosom Med. 2001; 63:49-55.
7 Insomnia Etiology Causes and comorbidities Situational disturbances Psychological conditioning hyperarousal Poor sleep habits Psychiatric disorders Medical disorders Sleep disorders Medication effects Often multifactorial Neubauer DN. Insomnia. Prim Care. 2005;32:
8 Insomnia: Two General Types Primary Insomnia independent from other disorders Comorbid Most common category Presumably associated with co-occurring medical, psychiatric, or sleep disorders Promotes independent treatment of insomnia and associated disorders Replaces secondary insomnia attribution NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. (June 15, 2005)
9 Models of Primary Insomnia Psychophysiological Hyperarousal EEG activation Cortisol and cytokine abnormalities Thermoregulation Neuroimaging Neubauer, David N. and Kelleen N. Flaherty Pathophysiology, Associations, and Consequences of Insomnia Handbook of Sleep Disorders. Edited by Kushida, C. Taylor and Francis Group, LLC New York, NY. 2010
10 Common Insomnia Comorbidities Medical Cardiac, pulmonary, rheumatologic, neurologic, endocrine, genitourinary, pain syndromes Psychiatric Mood disorders, anxiety disorders, substance abuse Sleep Circadian rhythm disorders, RLS Sleep disordered breathing Obstructive Central
11 More health problems Worse sleep Percent of community dwelling subjects (ages years) with any symptom of insomnia by number of medical conditions Reported Number of Medical Conditions N = 1506 Foley D, Ancoli Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: Results of the 2003 National Sleep Foundation Sleep in America survey. J Psychosom Res. 2004;56:
12 Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30:
13 Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30:
14 Medical Insomnia Increases Future Health Risks Hypertension (Japan) Coronary artery disease mortality (Sweden) Diabetes mellitus type II (Sweden, Germany) Psychiatric Mood disorders Anxiety disorders Substance abuse Suicide
15 Insomnia: Evaluation and Treatment
16 Evaluating Insomnia Screen patients for sleep-related symptoms Routine history Review of systems Recognize patients with increased risk for insomnia and other sleep disorders Do you feel that you are sleeping well at nighttime and are fully alert throughout the daytime?
17 Sleep Logs and Diaries Helpful in revealing patterns of sleep disturbance Sleep onset Sleep maintenance Advanced or delayed sleep phase tendencies Insufficient time in bed Helpful to monitor effects of treatment strategies Daily chart vs. graph approaches
18 Insomnia Treatment Approaches Education Sleep hygiene measures Behavioral and cognitive therapy techniques Pharmacotherapy Phototherapy and circadian manipulations Sleep medicine specialist consultation and sleep laboratory testing
19 Who Treats Insomnia Physicians Primary care Psychiatrist Multiple specialties Sleep medicine MDs Behavior sleep medicine specialists Nurses Nurse practitioners Physician assistants Therapists Collaborative efforts of all providers
20 Principles of Sleep Hygiene Regular sleep/wake cycle Regular exercise morning/afternoon Increase exposure to bright light during day Avoid exposure to bright light during night Avoid heavy meals/drinking <3 hrs of bedtime Enhance sleep environment Avoid caffeine, alcohol, nicotine Relaxing routine NHLBI Working Group on Insomnia NIH Publication
21 Strategy Cognitive therapy Relaxation training Sleep restriction Stimulus control Behavioral Strategies for Treating Insomnia Goal Bootzin RR, Perlis ML. J Clin Psych. 1992;53(suppl): Challenge patient s dysfunctional beliefs and misconceptions about sleep and insomnia Reduce physiologic and cognitive arousal at bedtime. Techniques include progression muscular relaxation, transcendental meditation, yoga, biofeedback Improve sleep continuity by limiting time spent in bed Relate to the bed/bedroom solely as a place for sleep or sexual activity
22 Cognitive-Behavioral Therapy (CBT) Multicomponent approach Sleep education and sleep hygiene advice Stimulus control and sleep restriction Cognitive psychotherapy Individual or group format Manualized or unstructured Numerous studies and meta-analyses demonstrate efficacy and long-term benefits
23 Advantages Cognitive-Behavioral Therapy (CBT) Efficacy and durability May address key psychological issues Appealing for some Disadvantages Availability of qualified therapists Cost in time and money Lack of immediate results Unappealing for others
24 CBT Outcomes CBT vs RT vs Placebo in 75 Chronic Primary Insomnia Patients Objective Measures of Efficacy Following 6 Weeks of Treatment 380 P= P=0.02 Total Sleep Time (Min) * Middle Wake Time After Sleep Onset (Min) * Placebo CBT RT Placebo CBT RT *RT vs placebo was nonsignificant. Edinger JD, et al. JAMA. 2001;285(14):
25 CBT Outcomes 105 Pretreatment 59 Studies Posttreatment (avg=5 wks) P< N = Minutes Minutes Sleep Onset Latency Wake After Sleep Onset CBT = cognitive-behavioral therapy Morin CM, et al. Am J Psychiatry. 1994;151: Total Sleep Time 0
26 Recent Insomnia Behavioral Treatment Reports Self-help therapy Internet-based interventions CBT with and without pharmacotherapy CBT for specific comorbid insomnia populations (depression, cancer) CBT and mindfulness medication Brief behavioral treatment Primary care nurses trained as sleep therapists Intensive sleep retraining
27
28 Substances Used for Sleep: Past to Present Fermented beverages Plant preparations Laudanum (opium/alcohol) Chloral hydrate Barbiturate and related compounds Antihistamines Benzodiazepine hypnotics Nonbenzodiazepine hypnotics Selective melatonin receptor agonist
29 Insomnia: Recent Highlights Pharmacologic Developments Pharmacodynamic innovations New mechanism of action medications Pharmacokinetic innovations Extended release hypnotics FDA insomnia treatment indications Duration of use Differentiating sleep onset and maintenance DEA scheduling for hypnotics
30 Insomnia Treatment Medications (FDA-Approved) Benzodiazepine receptor agonist hypnotics Benzodiazepine structure Nonbenzodiazepine Selective melatonin receptor agonist
31 Benzodiazepine Mechanisms Gamma aminobutyric acid (GABA) Predominant inhibitory neurotransmitter in CNS A primary inhibitory neurotransmitter in the ventrolateral preoptic nucleus (VLPO) Benzodiazepine receptor agonists (BZRA) bind to BZ receptor site on GABA A receptor complex Enhance GABA activation of chloride ion channel Hyperpolarizes GABAergic neurons Landolt HP, Gillin JC. CNS Drugs. 2000;15: Mendelson WB, et al. Sleep Med Rev. 2004;8:7-17.
32 GABA A Receptor Complex Extracellular Cl - Cl - Cl - γ Cl - Cl - BZ receptor site Cell membrane Intracellular Cl- Cl - Cl - Möhler H et al. (2002), J Pharmacol Exp Ther 300(1):2-8; Rowlett JK et al. (2005), CNS Spectr 10(1):40-48
33 Benzodiazepine Receptor Agonist Hypnotics Positive allosteric modulators of GABA responses at GABA A receptors Benzodiazepine and nonbenzodiazepine All promote rapid sleep onset Duration of action promoting sleep maintenance or causing residual sedation depends upon the dose and elimination halflife
34 Selective Melatonin Receptor Agonist Ramelteon (Rozerem) Selective melatonin receptor agonist MT 1 : attenuation of circadian alerting signal MT 2 : circadian phase reinforcement or shifting Acts on the suprachiasmatic nucleus Influences the circadian rhythm effects on the sleep-wake cycle No abuse liability, not a DEA controlled substance
35 Circadian and Homeostatic Regulation of Sleep Edgar DM, Dement WC, Fuller CA, et al. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent process in sleep-wake regulation. J Neurosci. 1993;13:
36 FDA Approved Insomnia Medications as of February, 2010 Generic name Brand name Available doses (mg) Elimination half life (hr) Benzodiazepine receptor agonists Benzodiazepines Immediate release Estazolam ProSom 1, Flurazepam Dalmane 15, Quazepam Doral 7.5, Temazepam Restoril 7.5, 15, 22.5, Triazolam Halcion 0.125, Nonbenzodiazepines Immediate release Eszopiclone Lunesta 1, 2, Zaleplon Sonata 5, 10 1 Zolpidem Ambien 5, Nonbenzodiazepines Extended release Zolpidem ER Ambien CR 6.25, Nonbenzodiazepines Alternate delivery Zolpidem oral spray Zolpimist 5, 10 ~2.5 Zolpidem sublingual Edluar 5, 10 ~2.5 Selective melatonin receptor agonist Ramelteon Rozerem
37 New Directions in Insomnia Pharmacotherapy Candidates in development Alternate delivery BZRA formulations* Doxepin ultra-low dose 5-HT 2A antagonists Orexin (Hypocretin) receptor antagonists CRF antagonists Neurosteroids, Substance P antagonists H 1 receptor antagonists (selective) H 3 receptor agonists
38 New Directions in Insomnia Pharmacotherapy MEDA Pharmaceuticals: Edluar NovaDel: Zolpimist
39 Summary Insomnia is a common clinical problem that is chronic for many individuals Effective treatment approaches include behavioral, cognitive, and pharmacologic interventions Insomnia treatment may involve the collaboration of a variety of health care providers There have been significant developments in both pharmacodynamic and pharmacokinetic approaches New approaches to delivering both cognitivebehavioral and pharmacologic insomnia therapies are being investigated.
40 Outcomes and Multidisciplinary Treatment of Insomnia David N. Neubauer, MD Johns Hopkins University School of Medicine References: 1. American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders : DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; Bootzin RR, Perlis ML. Nonpharmacologic treatments of insomnia. J Clin Psychiatry. 1992;53 Suppl: Buysse DJ. Chronic insomnia. Am J Psychiatry. 2008;165(6): Carey TJ, Moul DE, Pilkonis P, Germain A, Buysse DJ. Focusing on the experience of insomnia. Behav Sleep Med. 2005;3(2): Ebben MR, Spielman AJ. Non-pharmacological treatments for insomnia. J Behav Med. 2009;32(3): Edinger JD, Means MK. Cognitive-behavioral therapy for primary insomnia. Clin Psychol Rev. 2005;25(5): Edinger JD, Olsen MK, Stechuchak KM, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: A randomized clinical trial. Sleep. 2009;32(4): Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA. 2001;285(14): Espie CA, Broomfield NM, MacMahon KM, Macphee LM, Taylor LM. The attentionintention-effort pathway in the development of psychophysiologic insomnia: A theoretical review. Sleep Med Rev. 2006;10(4): Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26(28): Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: Implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39(1):45-60.
41 12. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: Results of the 2003 national sleep foundation sleep in america survey. J Psychosom Res. 2004;56(5): Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. an opportunity for prevention? JAMA. 1989;262(11): Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: Preliminary findings. J Clin Sleep Med. 2006;2(4): Harris J, Lack L, Wright H, Gradisar M, Brooks A. Intensive sleep retraining treatment for chronic primary insomnia: A preliminary investigation. J Sleep Res. 2007;16(3): Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8): Harvey AG, Sharpley AL, Ree MJ, Stinson K, Clark DM. An open trial of cognitive therapy for chronic insomnia. Behav Res Ther. 2007;45(10): Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med. 2001;63(1): Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: A 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28(11): Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: A 12-year follow-up study of a middle-aged swedish population. J Intern Med. 2002;251(3): Mendelson WB, Roth T, Cassella J, et al. The treatment of chronic insomnia: Drug indications, chronic use and abuse liability. summary of a 2001 new clinical drug evaluation unit meeting symposium. Sleep Med Rev. 2004;8(1): Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002;300(1): Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: An update. an american academy of sleep medicine report. Sleep. 2006;29(11): Morin AK. Strategies for treating chronic insomnia. Am J Manag Care. 2006;12(8 Suppl):S
42 25. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence ( ). Sleep. 2006;29(11): Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151(8): Morin CM, Vallieres A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA. 2009;301(19): National Institutes of Health. National institutes of health state of the science conference statement on manifestations and management of chronic insomnia in adults, june 13-15, Sleep. 2005;28(9): Neubauer DN. Insomnia. Prim Care. 2005;32(2): Ong JC, Shapiro SL, Manber R. Mindfulness meditation and cognitive behavioral therapy for insomnia: A naturalistic 12-month follow-up. Explore (NY). 2009;5(1): Riemann D, Perlis ML. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3): Ritterband LM, Thorndike FP, Gonder-Frederick LA, et al. Efficacy of an internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry. 2009;66(7): Rowlett JK, Cook JM, Duke AN, Platt DM. Selective antagonism of GABAA receptor subtypes: An in vivo approach to exploring the therapeutic and side effects of benzodiazepinetype drugs. CNS Spectr. 2005;10(1): Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5): Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in japanese male workers. J Occup Health. 2003;45(6): Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2): van Straten A, Cuijpers P. Self-help therapy for insomnia: A meta-analysis. Sleep Med Rev. 2009;13(1): Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep. 2009;32(6):
Insomnia Agents (Sherwood Employer Group)
Insomnia Agents (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf Link to
More informationBehavioral Sleep Medicine W 12:50p 3:50p, HPNP G103 CLP 7934 Section 03A4
Behavioral Sleep Medicine W 12:50p 3:50p, HPNP G103 CLP 7934 Section 03A4 Fall 2013 Instructor: Office hours: Christina McCrae, PhD, CBSM Department of Clinical & Health Psychology HPNP, Room 3139 csmccrae@phhp.ufl.edu
More informationPharmacological Help for a Good Night s s Sleep. Thomas Owens, MD
Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches
More informationLearning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017
Learning Objectives Characterize insomnia and its negative effects Management of Insomnia Discuss the goals of treatment Summarize guidelines of management of insomnia including non-pharmacologic and pharmacologic
More informationCPT David Shaha, MC US Army
CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case
More informationQuestion #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia
Evaluating Patients with Roger D. Seheult, M.D. Pulmonary Critical Care Physician - Beaver Medical Group, Redlands California Assistant Clinical Professor of Medicine - Loma Linda University School of
More informationInsomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier
Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how
More informationINSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4
INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep
More informationCognitive Behavioral Therapy for Chronic Insomnia: State of the Science Versus Current Clinical
Running Title: Cognitive Behavioral Therapy for Chronic Insomnia Cognitive Behavioral Therapy for Chronic Insomnia: State of the Science Versus Current Clinical Practices This article was published online
More informationCBT for Insomnia: Past, Present, and Future Directions
CBT for Insomnia: Past, Present, and Future Directions J. Todd Arnedt, Ph.D. Associate Professor of Psychiatry and Neurology Director, Behavioral Sleep Medicine Program Acting Director, Sleep and Circadian
More informationInsomnia. Arturo Meade MD
Insomnia Arturo Meade MD Goals Definition Prevalence Pathophysiology The role of Orexin Orexin receptor blockers Consequences: Daily Functioning Insomnia: Consequences Decreased quality of life
More informationInsomnia: Updates in Medical Management. Michael Newnam M.D.
Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian
More informationInsomnia treatment. Sleep hygiene education sleep hygiene teaches good sleeping habits. This includes:
Insomnia treatment INSOMNIA OVERVIEW insomnia is defined as difficulty falling asleep, difficulty staying asleep, or waking up early in the morning and not being able to return to sleep. In general, people
More informationSedative Hypnotics. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.11 Subject: Sedative Hypnotics Page: 1 of 7 Last Review Date: December 8, 2017 Sedative Hypnotics
More informationInsomnia treatment in primary care
Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu
More informationSedative Hypnotics. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.11 Subject: Sedative Hypnotics Page: 1 of 8 Last Review Date: September 15, 2016 Sedative Hypnotics
More informationInsomnia Disorder A Journey to the Land of No Nod
Insomnia Disorder A Journey to the Land of No Nod JACQUELINE D. KLOSS, PH.D. P S Y C H O L O G I S T B R Y N M A W R P S Y C H O L O G I C A L A S S O C I A T E S B E H A V I O R A L S L E E P M E D I
More informationInsomnia Treatment in Brief
Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Reference Number: CP.PMA_10.11.23 Effective Date: 07.16 Last Review Date: 04.18 Line of Business: Medicaid- Arizona (AHCS, CIC) Revision Log See Important Reminder
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.CPA.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at
More informationAddressing Pharmacologic Issues in. DSM-5 Sleep-Wake. Insomnia. Disorders. DSM-5 Insomnia Disorder. Insomnia. Disorder
Addressing Pharmacologic Issues in David N. Neubauer, MD Associate Professor of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine Baltimore, Maryland Restless Legs Syndrome Substance/
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Non-Benzodiazepine Insomnia Medications Reference Number: CP.HNMC.265 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder
More informationDSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)
DSM-5 INSOMNIA 3 nights/wk 3 months Difficulty Falling Asleep: > 30 minutes Difficulty Maintaining Sleep Next Day Consequences Early AM awakenings: (> 30 minutes before desired wake time) Initiation Trouble
More informationWhat is sleep? o Sleep is a body s rest cycle.
What is sleep? o Sleep is a state when our senses and motor actvity are relatively suspended; there is a total or partial unconsciousness and all voluntary muscles are inactive. o Sleep is a body s rest
More informationAnxiolytic and Hypnotic drugs
Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiety is unpleasant state of tension and fear that seems to arise from unknown source. The symptoms of severe anxiety are similar to those
More informationThis is the published version of a paper published in Behavioural and Cognitive Psychotherapy.
http://www.diva-portal.org This is the published version of a paper published in Behavioural and Cognitive Psychotherapy. Citation for the original published paper (version of record): Norell Clarke, A.,
More informationGoals. Brief Behavioural Interventions for Insomnia. What is insomnia? RCPsych International Congress, London 2014
Brief Behavioural Interventions for Insomnia RCPsych International Congress, London 2014 Dr David O Regan PhD MRCPsych, ST5 Higher Trainee Insomnia Clinic, Royal London Hospital for Integrated Medicine
More informationTITLE: Cognitive Behavioural Therapy for Insomnia in Adults: A Review of the Clinical Effectiveness
TITLE: Cognitive Behavioural Therapy for Insomnia in Adults: A Review of the Clinical Effectiveness DATE: 11 May 2010 CONTEXT AND POLICY ISSUES: Insomnia refers to difficulty initiating and/or maintaining
More informationObjectives. Disclosure. APNA 26th Annual Conference Session 2017: November 8, Kurtz 1. The speaker has no conflicts of interest to disclose
Christine Kurtz, DNP, PMHCNS BC Valparaiso University Disclosure The speaker has no conflicts of interest to disclose Objectives The learner will Describe the rationale for and five therapies of CBT I
More informationSleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER
Sleep Science: better sleep for you and your patients CHUNBAI ZHANG, MD MPH UW MEDICINE VALLEY MEDICAL CENTER Disclosure: Financial - none Non-Financial - none Selected Topics Sleep epidemiology Sleep
More informationThe Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationTreating Insomnia in Primary Care. Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team
Treating Insomnia in Primary Care Judith R. Davidson Ph.D., C. Psych. Kingston Family Health Team jdavidson@kfhn.net Disclosure statement Nothing to disclose A ruffled mind makes a restless pillow. ~ Charlotte
More informationCognitive-Behavioral Therapy for Insomnia
Wisconsin Department of Health Services Wisconsin Public Psychiatry Network Teleconference (WPPNT) This teleconference is brought to you by the Wisconsin Department of Health Services (DHS) Bureau of Prevention,
More informationComorbid insomnia is a relatively new term within
n report n Current and New Thinking in the Management of Comorbid Insomnia David N. Neubauer, MD Abstract Insomnia occurs predominantly in conjunction with a medical or psychiatric illness. New thinking
More information14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III
4:45 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationA Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment
A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment Jordan Pleskow, PharmD Roswell Park Cancer Institute Oncology Symposium 11/11/17 Objectives Evaluate the issues with sleep in
More informationCognitive Behavioral Therapy for Insomnia. Melanie K. Leggett, PhD, CBSM Duke University Medical Center
Cognitive Behavioral Therapy for Insomnia Melanie K. Leggett, PhD, CBSM Duke University Medical Center Disclosures I have no relevant financial relationship with the manufacturers of any commercial products
More informationManaging Insomnia Disorder A Review of the Research for Adults
Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said
More informationACTIVITY DESCRIPTION Target Audience Learning Objectives
ACTIVITY DESCRIPTION Target Audience This activity is designed to meet the needs of primary care providers, including primary care physicians, doctors of osteopathy, physician assistants, nurse practitioners,
More informationDefinitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months
Chronic Definitions Alon Y. Avidan, M.D., M.P.H UCLA Sleep Disorders Center Is a Distinct Disorder That Should Be Treated NIH (1983) 1 NIH (2005) 2 is a symptom, is a disorder not a disorder DSM-5 INSOMNIA
More information6/3/2015. Insomnia An Integrative Approach. Objectives. Why An Integrative Approach? Integrative Model. Definition. Short-term Insomnia
Insomnia An Integrative Approach Jeffrey S. Jump, M.D. Medical Director CHI Memorial Integrative Medicine Associates Objectives Understand the importance of sleep to health Identify patients with insomnia
More informationEffective Health Care Program
Comparative Effectiveness Review Number 159 Effective Health Care Program Management of Insomnia Disorder Executive Summary Introduction Sleep problems are common concerns for adults. 1 Compromised sleep
More informationCase Studies of Chronic Insomnia Patients Participating in Group Cognitive Behavioral Therapy for Insomnia
online ML Comm BRIEF COMMUNICATION pissn 2093-9175 / eissn 2233-8853 Sleep Med Res 2012;3:45-49 Case Studies of Chronic Insomnia Patients Participating in Group Cognitive Behavioral Therapy for Insomnia
More informationPharmacy Medical Necessity Guidelines: Insomnia Treatments
Pharmacy Medical Necessity Guidelines: Effective: January 1, 2019 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
More informationInsomnia. Dr Terri Henderson MBChB FCPsych
Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change
More informationModern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep
More informationWHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?)
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHEN SHOULD I USE SLEEP AIDS IN MY PATIENTS WITH SLEEP DISORDERS... (AND WHEN SHOULD I NOT?) CATHERINE MCCALL, MD
More informationHetlioz (tasimelteon)
Hetlioz (tasimelteon) Policy Number: 5.01.687 Last Review: 01/2019 Origination: 01/2019 Next Review: 01/2020 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Hetlioz
More information14. Percent
4:30 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau
More informationUtilizing Cognitive-Behavioral Therapy for Insomnia to Facilitate Discontinuation of Sleep Medication in Chronic Insomnia Patients
Pharmacological Treatment of Insomnia: Hypnotic Medication Historically, pharmacotherapy has been the first line treatment for insomnia and remains a popular choice of treatment. 8,9 Approximately 3 to
More informationInsomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)
10-15% of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 30 40% of adults complain of insomnia symptoms only 95% experience insomnia at some time in their
More informationComparison of Insomnia Treatments
PL Detail-Document #280504 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER May 2012 Comparison of Insomnia
More informationTreating sleep disorders
Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with
More informationDiagnosis and Treatment of Chronic Insomnia: A Review. underdiagnosed, and undertreated
Diagnosis and Treatment of Chronic Insomnia: A Review Ruth M. Benca, M.D., Ph.D. Objective: Insomnia has high prevalence rates and is associated with significant personal and socioeconomic burden, yet
More informationAmbien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that
22-10-2013 Ambien vs Rozerem There are people out there who have trouble falling asleep at night. Â Often, this would be considered as a disease that can be treated with Ambien vs Rozerem. Ambien:. Ramelteon
More informationTRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE
TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES. SEDATIVE HYPNOTIC AGENTS Generic Brand HICL GCN Exception/Other ZOLPIDEM
Generic Brand HICL GCN Exception/Other ZOLPIDEM AMBIEN 07842 GENERIC IS UNRESTRICTED TARTRATE AMBIEN CR EDLUAR INTERMEZZO ZOLPIMIST ESZOPICLONE LUNESTA 26791 GENERIC IS UNRESTRICTED RAMELTEON ROZEREM 33126
More informationModern Management of Sleep Disorders
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationLEARNING OBJECTIVES SLEEP APNEA
LEARNING OBJECTIVES List key differences between insomnia and obstructive sleep apnea Identify at least two appropriate pharmacologic treatment options for insomnia INSOMNIA VS. SLEEP APNEA Morganne Smyth,
More informationPsychopharmacology of Sleep Disorders
Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry
More informationModern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco
Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance
More informationDr Alex Bartle. Sleep Well Clinic
Dr Alex Bartle Sleep Well Clinic Overview of Sleep Disorders Sleep: Why bother. Effect of Poor Quality or reduced Quantity of Sleep Common Sleep Disorders Management of Insomnia Medication vs CBTi Conclusion
More informationSLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla
SLEEP-WAKE DISORDERS: INSOMNIA Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS AND ICD-10 Chapter V: Mental and Behavioural Disorders F51. Non-organic sleep disorders Chapter VI: Nervous System Illnesses G47.
More informationSleep and Parkinson's Disease
Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu
More informationDiagnostic and treatment challenges for patients with insomnia and major depression
Diagnostic and treatment challenges for patients with insomnia and major depression Colleen E Carney, PhD Ryerson University Associated Professional Sleep Societies, LLC 1 Conflict of Interest Disclosures
More informationSleeping your way to better mental health
Sleeping your way to better mental health Liverpool PWP Master Class 28 th January 2015 Dr Sophie Bostock sophie@sleepio.com Sleep Matters What we ll cover today.. 1. Sleep and mental health are intimately
More informationADULT PRIMARY INSOMNIA
Clinical Practice Guideline Adult Primary Insomnia: Diagnosis to Management 2007 Update This guideline was developed by a Clinical Practice Guidelines Working Group to assist physicians in the management
More informationChronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age
Insomnia Management in the Digital Age Dr Anup Desai Sleep & Respiratory Medicine MBBS (syd), PhD (syd), FRACP Senior Staff Specialist, POW Hospital Medical Director, Sydney Sleep Centre Senior Lecturer,
More informationSEDATIVE-HYPNOTIC AGENTS
SEDATIVE-HYPNOTIC AGENTS Documentation A. FDA approved indications 1. Insomnia 2. Sedation for an agitated patient in an inpatient setting Documentation B. Non-FDA approved, commonly used indications 1.
More informationDRUGS THAT ACT IN THE CNS
DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment
More informationSleep Hygiene. William M. DeMayo, M.D. John P. Murtha Neuroscience and Pain Institute Conemaugh Health System Johnstown, PA
Sleep Hygiene William M. DeMayo, M.D. John P. Murtha Neuroscience and Pain Institute Conemaugh Health System Johnstown, PA Why Is Sleep Important? Symptoms of Sleep Deprivation: Irritability / Poor Stress
More informationInsomnia: habits, help, and hazards
Insomnia: habits, help, and hazards Balanced data about medications www.rxfacts.org Copyright 2010 by The Alosa Foundation www.rxfacts.org November 2010 2 www.rxfacts.org Author: Leslie Jackowski, B.Sc.,
More informationSleep Disorders and Insomnia
7:45 8:45 am Management of Insomnia and Other Disorders SPEAKER Alon Y. Avidan, MD, MPH, FAAN, FAASM Presenter Disclosure Information The following relationships exist related to this presentation: Alon
More informationIpopulation, approximately 10% to 15% of people report
Cognitive-Behavioral Treatment of Insomnia Cognitive-Behavioral Approaches to the Treatment of Insomnia Charles M. Morin, Ph.D. Insomnia is a pervasive condition with various causes, manifestations, and
More informationHelping Patients with Insomnia: A Guide for the Primary Care Physician
case-based review Helping Patients with Insomnia: A Guide for the Primary Care Physician Case Study and Commentary, Leslie M. Swanson, PhD, and J. Todd Arnedt, PhD This article has a companion CME exam
More informationAvailable Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED
More informationAddressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling
Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:
More informationWeekly Sleep Diary. Name Instructions: Keep this at your bedside and complete each morning upon awakening. Day of the week. Total Sleep Time (TST)
Weekly Sleep Diary Name Instructions: Keep this at your bedside and complete each morning upon awakening. Day of the week Calendar date Yesterday, I napped for: (add total naps, eg., 15 mins, ½, 1, 2 hrs,
More informationDrug Review Rozerem (ramelteon)
Drug Review Rozerem (ramelteon) Introduction 1 Ramelteon is a melatonin receptor agonist with affinity for MT 1 and MT 2 and selectivity over the MT 3 receptor. The activity at the MT 1 and MT 2 receptors
More informationInsomnia Pharmacotherapy A Practical Guide for Primary Care
Insomnia Pharmacotherapy A Practical Guide for Primary Care Offices in Jacksonville, Florida Fortis Spectrum is the educational partner for this session. Session 3: Insomnia Pharmacotherapy: A Practical
More informationSleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know
Sleep and Insomnia Everything you wanted to know Presented by Marie Rataj, MSN, APRN, ANP Objectives Develop a basic knowledge of normal sleep and differentiate from abnormal sleep Develop basic understanding
More informationInsomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D
St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4
More informationDrug Class Review on Newer Drugs for Insomnia
Drug Class Review on Newer Drugs for Insomnia Final Report July 00 The Agency for Healthcare Research and Quality has not yet seen or approved this report The purpose of this report is to make available
More informationYour sleep is a reflection of your life
Sleep Disorders and Developmental Disabilities Rafael Pelayo, MD Do you really want to sleep like a baby? He/She won t sleep What goes through your mind when you hear this?? Your life is reflected in your
More informationBeyond Sleep Hygiene: Behavioral Approaches to Insomnia
Beyond Sleep Hygiene: Behavioral Approaches to Insomnia Rocky Garrison, PhD, CBSM Damon Michael Williams, RN, PMHNP-BC In House Counseling Laughing Heart LLC 10201 SE Main St. 12 SE 14 th Ave. Suite 10
More information일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌
개원의와함께하는임상강좌 2011 일차진료에서불면증치료 경희대학교의과대학정신과학교실 김종우 Diagnostic Criteria for Insomnia (ICSD-2) International Classification of Sleep Disorders, 2nd Edition (ICSD-2) Primary Insomnia : DSM-IV criteria A. The
More informationOptimal Sleep Using NeurOptimal -Insomnia Studies
Optimal Sleep Using NeurOptimal -Insomnia Studies Edward B. O'Malley, PhD, FAASM Diplomate, American Board of Sleep Medicine Managing Director, Sleep HealthCare of CT Fairfield, CT eomalley@sleephelathcarect.com
More informationSleep Clinic Case: History. Insomnia in Patients with Comorbid Psychiatric Disorders: Shared Neurobiology and Clinical Solutions
Sleep Clinic Case: History Insomnia in Patients with Comorbid Psychiatric Disorders: Shared Neurobiology and Clinical Solutions David N. Neubauer, MD Associate Professor Johns Hopkins University School
More informationMINDFULNESS MEDITATION AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA: A NATURALISTIC 12-MONTH FOLLOW-UP
ORIGINAL RESEARCH MINDFULNESS MEDITATION AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA: A NATURALISTIC 12-MONTH FOLLOW-UP Jason C. Ong, PhD, 1,# Shauna L. Shapiro, PhD, 2 and Rachel Manber, PhD 1 A unique
More informationOutline. Disclosure. Sleep and the Elderly 1,2. Background
Geriatric Grand Rounds Tuesday, March 31, 29 12: noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this
More informationTreatment of Insomnia for Clinicians
Treatment of Insomnia for Clinicians Larry Pawluk, M.D., FRCPC Diplomate, American Board of Sleep Medicine Clinical Professor of Psychiatry, Sleep Medicine Program, University of Alberta What is Insomnia?
More informationDrug Class Update: Sedatives
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationSedative / Hypnotics
Sedative / Hypnotics David H. Rubin, MD Executive Director, Massachusetts General Hospital Psychiatry Academy Director of Child and Adolescent Psychiatry Residency Training Massachusetts General Hospital
More informationFaculty/Presenter Disclosure
A Little CBT I With My Tea Please: Cognitive Behavioural Therapy for insomnia (CBT I) and Its Use In the Treatment of Sleeplessness W. Jerome Alonso, MD Medical Director, Canadian Sleep Consultants Clinical
More information8/29/2013. Discuss Relation of Fatigue to Sleep Disturbance. Assessing and Treating Factors Contributing to Fatigue and Sleep Disturbance
Timothy Pearman, Ph.D. Director, Supportive Oncology Robert H. Lurie Comprehensive Cancer Center Associate Professor of Medical Social Sciences and Psychiatry Northwestern University Feinberg School of
More informationIndex. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Accidents, risk of, with insufficient sleep, 318 Acquired immunodeficiency syndrome (AIDS), comorbid with narcolepsy, 298 299 Actigraphy, in
More informationINSOMNIA IN THE AGEING POPULATION: CHARACTERISATION AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES
INSOMNIA IN THE AGEING POPULATION: CHARACTERISATION AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES *Katie Moraes de Almondes Department of Psychology, Federal University of Rio Grande do Norte, Natal, Brazil
More informationYou May Be at Risk. You are taking one of the following sedative-hypnotic medications:
You May Be at Risk You are taking one of the following sedative-hypnotic medications: Alprazolam (Xanax ) Bromazepam (Lectopam ) Chlorazepate Chlordiazepoxideamitriptyline Clidinium-chlordiazepoxide Clobazam
More informationTOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children
TOP 10 LIST OF SLEEP QUESTIONS Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children QUESTION #1: ARE SLEEP ISSUES IN CHILDREN THE SAME AS IN ADULTS? Distinctive Features
More informationCognitive behavioural therapy for insomnia
Cognitive behavioural therapy for insomnia Item type Authors Citation Publisher Journal Article Ruth, Alan Ruth A. Cognitive behavioural therapy for insomnia. Nurs Gen Prac 2014 May 29-30, 32 Nursing in
More information